Bruce Cahill v. Paul Edalat

• Court: Court of Appeals for the Ninth Circuit
• Decided: July 8, 2021
• Docket: 17-56826
• Status: Unpublished

Opinion

NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS JUL 8 2021 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT

BRUCE CAHILL; et al., Nos. 17-56826, 17-56894, 18- 55171 Appellees/Cross-Appellants, D.C. No. 8:16-cv-00686-AG-DFM v.

PAUL EDALAT; OLIVIA MEMORANDUM* KARPINSKI,

Appellants/Cross-Appellees.

Appeal from the United States District Court for the Central District of California Andrew Guilford, District Judge, Presiding

Argued and Submitted May 3, 2021 Pasadena, California

Before: OWENS and LEE, Circuit Judges, and SIMON **, District Judge.

Pharma Pak Inc., a marijuana-related venture, faltered, leading to this legal

fracas in which the company’s investors and employees sued each other on a wide

variety of claims. Bruce Cahill, Ron Franco, and Greg Cullen brought claims of

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.

** The Honorable Michael H. Simon, United States District Judge for the District of Oregon, sitting by designation.

1 fraud and defamation against Paul Edalat and Olivia Karpinski. In response, Edalat

and Karpinski asserted counterclaims against Cahill — Edalat for breach of fiduciary

duty, and Karpinski for sexual harassment and other employment-related claims.

Both sides won some and lost some at trial, and both sides now appeal various

aspects of the district court’s trial and post-trial rulings. As the parties are familiar

with the facts, we do not recount them here. We have jurisdiction under 28 U.S.C.

§ 1291, and we affirm.

1. The district court did not err in instructing the jury on Edalat’s breach

of fiduciary duty claim. In our view, the jury instruction accurately reflects the legal

rules set out in California Corporations Code § 310(a), which governs corporate

transactions involving interested shareholders. “Section 310(a) provides that a vote

on the matter is not void or voidable because the interested director is present at the

board meeting if one of three alternatives are satisfied.” Sammis v. Stafford, 56 Cal.

Rptr. 2d 589, 592 (Ct. App. 1996). The first two alternatives involve situations

where a disinterested majority vote is still possible, whether by barring the interested

shareholder from voting, or by not counting the interested shareholder’s vote. The

third alternative involves situations where a transaction is “based on a vote by the

interested director.” Id. at 594. Under those circumstances, the interested

shareholder bears the burden of proving that the transaction was just and reasonable.

Cal. Corp. Code § 310(a)(3).

2 Here, the jury instruction captures all three alternatives. First, the instruction

provides that “a sale or other transfer of the assets of a Pharma Pak Inc. must have

been approved by a majority of the shareholders of Pharma Pak Inc.” Then, in the

case of an interested transaction, the instruction says that one of three additional

requirements, including the “just and reasonable” requirement, “must have also been

met” on top of the baseline majority approval requirement. Finally, the jury

instruction states that if there was no “proper authorization” for the transaction, then

there was a breach of fiduciary duty. Cahill argues that the jury instruction directed

the jury to find in favor of Edalat as long as there was no “authorization” for the

asset transfer, without considering whether the transaction was just and reasonable.

We read the phrase “authorization” to mean that one of the three alternatives listed

immediately above in the instructions — including the “just and reasonable”

requirement — was satisfied. In other words, the jury could not have found a breach

of fiduciary duty without first considering whether the transaction was just and

reasonable. We therefore reject Cahill’s jury instruction challenge on cross-appeal.

2. The district did not err when it entered judgment on the fiduciary duty

claim in favor of Edalat in his individual shareholder capacity instead of in favor of

Pharma Pak as a corporation. As a threshold matter, Cahill did not waive his

objection to the entry of judgment in favor of Edalat in his direct shareholder

capacity. It was not clear from the pre-trial filings that Edalat intended to submit

3 only a direct, not a derivative, claim to the jury, and when it did become clear, Cahill

timely filed an objection to the proposed judgment form.

Turning to the substance of the argument, Cahill asserts on cross-appeal that

the fiduciary duty claim in this case could only have been brought as a derivative

claim on behalf of the corporation, not as a direct claim on behalf of Edalat in his

individual capacity. In general, “an action is derivative if the gravamen of the

complaint is injury to the corporation, or to the whole body of its stock or property

without any severance of distribution among individual holders, or if it seeks to

recover assets for the corporation or to prevent the dissipation of its assets.” Schuster

v. Gardner, 25 Cal. Rptr. 3d 468, 473 (Ct. App. 2005) (cleaned up). In contrast, an

action can be brought in an individual capacity “only where it appears that the injury

resulted from the violation of some special duty owed the stockholder by the

wrongdoer and having its origin in circumstances independent of the plaintiff’s

status as a shareholder.” Nelson v. Anderson, 84 Cal. Rptr. 2d 753, 761 (Ct. App.

1999) (cleaned up).

In this case, the jury awarded Edalat $250,000 in damages on the fiduciary

duty claim. Based on the trial transcript, we are convinced that this award was only

meant to compensate Edalat for his individual harms. It would be one thing, for

instance, if the $250,000 was solely meant to compensate Edalat for the devaluation

of his Pharma Pak stock; in that case, Edalat would be in the same position as every

4 other Pharma Pak shareholder because all Pharma Pak stock would have been

devalued as a result of the unauthorized asset transfer.1 See Everest Invs. 8 v. McNeil

Partners, 8 Cal. Rptr. 3d 31, 41-42 (Ct. App. 2003); Sax v. World Wide Press, Inc.,

809 F.2d 610, 614 (9th Cir. 1987).

But here, the trial transcript suggests that the only realistic basis for the

$250,000 award was the amount of money that Cahill personally owed Edalat in his

individual capacity. Specifically, when Cahill bought stock in Pharma Pak, he

bought the stock directly from Edalat, paying Edalat $500,000. Half of that sum

went directly to Edalat, while the other half went into the company to satisfy Edalat’s

capital call. But due to the unauthorized asset transfer, Edalat never saw the benefit

of the latter $250,000. That loss is distinct from the loss suffered by the company

as a whole, because it is more akin to the breach of a contractual obligation between

Cahill and Edalat, as opposed to being merely incidental to the devaluation of the

1 During closing arguments, Edalat’s counsel asked the jury to award Edalat $6,320,000 in damages for the breach of fiduciary duty by Cahill. That number was taken directly from the value of the assets transferred from Pharma Pak to Life Tech Global: Life Tech Global was (allegedly) worth $20 million, which meant the transferred Pharma Pak assets were worth $20 million, and because Edalat owned 31.6 percent of Pharma Pak, Edalat was thus entitled to 31.6 percent of $20 million, or $6,320,000. If the jury did indeed award Edalat the lost value of his shares, then this claim would more closely resemble a derivative claim. But ultimately, we see nothing in the record to suggest that the jury’s $250,000 award was in fact tied to the supposedly lost value of Edalat’s ownership share in Pharma Pak. Indeed, the jury was not required to accept Edalat’s proposed $6,320,000 valuation of his ownership share in Pharma Pak. 5 company as a whole. For that reason, we hold that the district court did not err in

entering judgment in favor of Edalat in his individual capacity.

3. The district court did not abuse its discretion when it denied Edalat’s

post-trial motion for the imposition of a constructive trust over the assets of Life

Tech Global for the benefit of Pharma Pak. “A constructive trust is an involuntary

equitable trust created by operation of law as a remedy to compel the transfer of

property from the person wrongfully holding it to the rightful owner.” Meister v.

Mensinger, 178 Cal. Rptr. 3d 604, 618-19 (Ct. App. 2014) (cleaned up). “The

propriety of granting equitable relief of imposition of a constructive trust rests within

the sound discretion of the trial court.” GHK Assocs. v. Mayer Grp., Inc., 274 Cal.

Rptr. 168, 182 (Ct. App. 1990). “It is up to the trial court to decide if such a trust is

preferable to the other available remedies.” Meister, 178 Cal. Rptr. 3d. at 620.

Edalat’s motion essentially boils down to the argument that, because the jury

found in favor of Edalat in his individual shareholder capacity on the fiduciary duty

counterclaim, then that exact same finding doubles as proof for the derivative claim

on behalf of Pharma Pak, and the district court must impose the constructive trust

remedy in favor of Pharma Pak. But as mentioned above, the constructive trust

remedy is discretionary, not mandatory. And more importantly, the district court

denied the constructive trust motion because it was not persuaded by Edalat’s “view

of what the jury found.” In other words, it was possible for the jury to find that the

6 unauthorized asset transfer harmed Edalat by depriving him of funds that Cahill

personally owed him, while simultaneously declining to find that the asset transfer

harmed the company as a whole. Thus, it does not necessarily follow that a jury

finding in favor of Edalat on his individual shareholder claim must support the

remedy of a constructive trust on the derivative claim in favor of the company. The

district court could have explained its decision in more detail, but overall, we do not

think the denial of the constructive trust motion was an abuse of discretion.

4. The district court did not abuse its discretion when it allowed Cullen

and Franco to proceed in their individual capacities, instead of in their capacities as

trustees for their respective trusts. Federal Rule of Civil Procedure 17 states that

courts must allow parties a reasonable opportunity to substitute the real party in

interest after an objection has been made. Here, Edalat attempted to argue at trial

that Cullen and Franco purchased Pharma Pak stock in their trustee capacities, not

their individual capacities. To the extent that that line of argument can be construed

as an objection, the district court did not abuse its discretion in granting Cullen and

Franco’s request to instruct the jury to assume that Cullen and Franco had brought

the claims in the correct capacities. Moreover, there is no indication that Edalat was

prejudiced by the substitution, which was ultimately meant to correct a naming

technicality. See Jones v. Las Vegas Metro. Police Dep’t, 873 F.3d 1123, 1128 (9th

Cir. 2017). This is not a scenario, for instance, where entirely new parties were

7 allowed to join the case at the last minute; Cullen and Franco were involved in the

litigation from the very start. We thus hold that the district court did not abuse its

discretion in crafting a last-minute solution to the real-party-in-interest issue.

5. The district court did not err when it declined to attach a public-figure

jury instruction to Cahill’s defamation claims against Edalat and Karpinski. See New

York Times Co. v. Sullivan, 376 U.S. 254, 279-80 (1964). Because Edalat is arguing

that the district court made a legal error, we review the district court’s decision de

novo. Peralta v. Dillard, 744 F.3d 1076, 1082 (9th Cir. 2014) (en banc). We agree

with the district court that Cahill, as a trustee for the University of California at Irvine

Foundation, was not a public figure for purposes of the defamation analysis.

First, we are not persuaded that a trustee of the University of California at

Irvine Foundation — which is distinct from the university itself — occupies a

position “of such persuasive power and influence” that he should be deemed an all-

purpose public figure. Makaeff v. Trump Univ., LLC, 715 F.3d 254, 265 (9th Cir.

2013) (citation omitted). We also reject the argument that Cahill has “actual or

apparent substantial responsibility” over government affairs. See Rosenblatt v. Baer,

383 U.S. 75, 85 (1966). Similarly, Edalat did not provide any evidence to suggest

that Cahill should be treated as a limited-purpose public figure. See Makaeff, 715

F.3d at 266. The mere fact that Edalat himself tagged UC Irvine in some of the

defamatory online posts is not sufficient to establish that Cahill himself voluntarily

8 injected himself into any public controversy. Nor does the content of the posts have

anything to do with Cahill’s trustee position or his work with the foundation. Thus,

we affirm the district court’s decision to not provide a public-figure instruction.

6. The district court did not abuse its discretion when it provided the jury

with a general verdict form instead of Edalat’s proposed special verdict form. “As

a general rule, the court has complete discretion over whether to have the jury return

a special verdict or a general verdict.” Floyd v. Laws, 929 F.2d 1390, 1395 (9th Cir.

1991). In this case, the district court explained that a general verdict form would be

easier for the jury to understand in light of the number of claims and parties involved

in the case. The district court also considered Edalat’s argument that a general

verdict form might make it difficult to calculate attorney fees at the post-trial stage,

but the parties agreed that the only claims for which attorney fees were available

would be resolved by the court in a bench trial. Although one of Karpinski’s jury

claims did ultimately give rise to a discretionary fee award, the district court’s denial

of attorney fees was unrelated to the use of a general verdict, as explained in more

detail below.

7. The district court did not err when it denied Edalat’s post-trial motion

challenging the defamation verdict in favor of Cullen and Franco. The relevant jury

instruction correctly stated that the statements in question could only be defamatory

if they were “reasonably understood” to be “about that plaintiff.” And here, the

9 relevant Twitter posts were published on the same day and appear right next to one

another on Edalat’s Twitter page, which was screenshotted and presented to the jury

in an exhibit. One of the posts does not reference Cullen or Franco by name, but the

post right next to it does.

Edalat challenges the authenticity of this exhibit on appeal but failed to object

to the exhibit at trial, so that argument is waived. See Marbled Murrelet v. Babbitt,

83 F.3d 1060, 1066 (9th Cir. 1996). Accepting that what the jury saw was an

accurate depiction of Edalat’s Twitter page, then the question is whether the only

reasonable conclusion from the record is that the defamatory post did not refer to

either Cullen or Franco. See Lam v. City of Los Banos, 976 F.3d 986, 995 (9th Cir.

2020). We hold that it was not unreasonable for the jury to rely on context clues to

conclude that the defamatory Twitter post referred to Cullen and Franco. We thus

affirm the district court’s denial of Edalat’s post-trial motion on this issue.

8. The district court did not abuse its discretion when it denied Edalat’s

motion for a new trial based on undisclosed evidence. In seeking a new trial based

on Cahill’s withheld loan application, Edalat was required to “prove by clear and

convincing evidence that the verdict was obtained through fraud, misrepresentation,

or other misconduct,” and “establish that the conduct complained of prevented him

from fully and fairly presenting his case or defense.” Wharf v. Burlington N. R. Co.,

60 F.3d 631, 637 (9th Cir. 1995) (citation omitted). “A new trial is warranted only

10 if counsel’s misconduct affected the verdict.” Mateyko v. Felix, 924 F.2d 824, 828

(9th Cir. 1990). We agree with the district court that Edalat has failed to meet his

high burden of showing that “not having access to Cahill’s loan application”

prevented him from “fully and fairly” presenting his case.

Assuming for the sake of argument that Cahill affirmatively misrepresented

the relevance of the loan application, Edalat has failed to show that the evidence

would have affected the verdict. Cahill argues that the loan application would have

undermined Cahill’s fraud and defamation claims by proving that Cahill believed

Pharma Pak had value and that Cahill was indeed a criminal who committed bank

fraud. Both arguments are highly speculative and are insufficient to show that the

fraud and defamation verdicts would have come out the other way if the loan

application evidence had been introduced. So the district court did not abuse its

discretion in denying Edalat’s motion for a new trial.

9. Finally, the district court did not abuse its discretion when it denied

Karpinski’s motion for attorney fees. The general verdict makes it hard to tell

exactly which claim or claims Karpinski prevailed on, but the district court

acknowledged that Karpinski could be entitled to the discretionary award of attorney

fees under the California Fair Employment and Housing Act (“FEHA”) and

conducted the fee analysis based on the assumption that Karpinski prevailed on her

FEHA claim. The district court then declined to award fees given the convoluted

11 nature of the case. Courts are allowed to deny attorney fees under FEHA when the

fee request is greatly inflated compared to the scope of success, Chavez v. City of

Los Angeles, 224 P.3d 41, 54 (Cal. 2010), and in this case, Karpinski seeks over

$169,000 in fees despite recovering only $10,000 in damages. Although it would

have been preferable for the district court to have explained the denial in more detail,

we do not think the denial rises to the level of abuse of discretion.

AFFIRMED.